Leclerc JR - Search Results

1

Clinical prediction of deep vein thrombosis in patients with leg symptoms.

Kahn SR, Joseph L, Abenhaim L, Leclerc JR. Kahn SR, et al. Among authors: leclerc jr. Thromb Haemost. 1999 Mar;81(3):353-7. Thromb Haemost. 1999. PMID: 10102459 Clinical Trial.

2

Prevention of deep vein thrombosis after major knee surgery--a randomized, double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo.

Leclerc JR, Geerts WH, Desjardins L, Jobin F, Laroche F, Delorme F, Haviernick S, Atkinson S, Bourgouin J. Leclerc JR, et al. Thromb Haemost. 1992 Apr 2;67(4):417-23. Thromb Haemost. 1992. PMID: 1321509 Clinical Trial.

3

Technetium-99m red blood cell venography in patients with clinically suspected deep vein thrombosis: a prospective study.

Leclerc JR, Wolfson C, Arzoumanian A, Blake GP, Rosenthall L. Leclerc JR, et al. J Nucl Med. 1988 Sep;29(9):1498-506. J Nucl Med. 1988. PMID: 3411373

4

A randomized management study of impedance plethysmography vs. contrast venography in patients with a first episode of clinically suspected deep vein thrombosis.

Kahn SR, Joseph L, Grover SA, Leclerc JR. Kahn SR, et al. Among authors: leclerc jr. Thromb Res. 2001 Apr 1;102(1):15-24. doi: 10.1016/s0049-3848(01)00222-5. Thromb Res. 2001. PMID: 11323010 Clinical Trial.

5

The incidence of symptomatic venous thromboembolism after enoxaparin prophylaxis in lower extremity arthroplasty: a cohort study of 1,984 patients. Canadian Collaborative Group.

Leclerc JR, Gent M, Hirsh J, Geerts WH, Ginsberg JS. Leclerc JR, et al. Chest. 1998 Aug;114(2 Suppl Evidence):115S-118S. doi: 10.1378/chest.114.2_supplement.115s. Chest. 1998. PMID: 9726704 Clinical Trial. No abstract available.

6

Accuracy of sonography in the evaluation of calf deep vein thrombosis in both postoperative surveillance and symptomatic patients.

Atri M, Herba MJ, Reinhold C, Leclerc J, Ye S, Illescas FF, Bret PM. Atri M, et al. AJR Am J Roentgenol. 1996 Jun;166(6):1361-7. doi: 10.2214/ajr.166.6.8633448. AJR Am J Roentgenol. 1996. PMID: 8633448

7

A new thrombus imaging agent. Human recombinant fibrin binding domain labeled with In-111.

Rosenthall L, Leclerc J. Rosenthall L, et al. Clin Nucl Med. 1995 May;20(5):398-402. doi: 10.1097/00003072-199505000-00004. Clin Nucl Med. 1995. PMID: 7628140 Clinical Trial.

8

Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.

Levine MN, Hirsh J, Gent M, Turpie AG, Weitz J, Ginsberg J, Geerts W, LeClerc J, Neemeh J, Powers P, et al. Levine MN, et al. Thromb Haemost. 1995 Aug;74(2):606-11. Thromb Haemost. 1995. PMID: 8584992 Clinical Trial.

9

A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study.

Turpie AG, Gent M, Côte R, Levine MN, Ginsberg JS, Powers PJ, Leclerc J, Geerts W, Jay R, Neemeh J, et al. Turpie AG, et al. Ann Intern Med. 1992 Sep 1;117(5):353-7. doi: 10.7326/0003-4819-117-5-353. Ann Intern Med. 1992. PMID: 1503326 Clinical Trial.

10

Recurrent leg symptoms following deep vein thrombosis. A diagnostic challenge.

Leclerc JR, Jay RM, Hull RD, Hirsh J. Leclerc JR, et al. Arch Intern Med. 1985 Oct;145(10):1867-9. Arch Intern Med. 1985. PMID: 4037947 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results